Myocarditis is generally a mild and self-limited consequence of systemic infection of
cardiotropic viruses. However, patients can develop a temporary or permanent impairment …

Inflammatory activation occurs in nearly all forms of myocardial injury. In contrast,
inflammatory cardiomyopathies refer to a diverse group of disorders in which inflammation of …

In the past two decades, porous silicon (PSi) has attracted increasing attention for its
potential biomedical applications. With its controllable geometry, tunable nanoporous …

Abstract Background Cyclosporin A (CsA) is a promising therapeutic drug for myocardial
ischemia reperfusion injury (MI/RI) because of its definite inhibition to the opening of …

The effective delivery of antioxidants to the cells is hindered by their high metabolization
rate. In this work, quercetin was encapsulated in poly (lactic‐co‐glycolic) acid (PLGA) …

Myocarditis is defined as an inflammatory infiltration of the myocardium with associated
necrosis and/or degeneration, frequently resulting from different infectious or non-infectious …

The role of the mitochondrial calcium uniporter (MCU) in energy dysfunction and
hypertrophy in heart failure (HF) remains unknown. In angiotensin II (ANGII)–induced …

The adult myocardium has a limited regenerative capacity following heart injury, and the lost
cells are primarily replaced by fibrotic scar tissue. Suboptimal efficiency of current clinical …

Efficient delivery of antioxidant drugs into mitochondria of ischemic cardiomyocytes where
reactive oxygen species largely induced is a major challenge for precise treatment of …

Background Silica nanoparticles (nanoSiO 2) are promising systems that can deliver
biologically active compounds to tissues such as the heart in a controllable manner …